Assuming treatments is required, the following results were found.

  • #ECTRIMS2019 - Are Injectables Inappropriate for Active Relapsing MS? - Multiple Sclerosis News Today

    held in Stockholm, in which two speakers discussed the benefits and risks of low- versus high-efficacy disease-modifying treatments (DMTs). Gisela Kobelt, PhD, a health economist and president of the European Health Economics Association in France,...

    https://mschristian.org/index.php/blog/ectrims2019-are-injectables-inappropriate-for-active-relapsing-ms-multiple-sclerosis-news-today
  • Infusion Treatments: Benefits and Side Effects

    your nerves. Then it may start to harm the nerves themselves. There’s no cure for MS, but there are several types of treatments. In some cases, treatment can slow the pace of MS. Treatment can also help ease symptoms and reduce potential damage done by...

    https://mschristian.org/index.php/blog/infusion-treatments-benefits-and-side-effects
  • NIH trial aims to improve drug discovery for ischemic stroke

    a nationwide preclinical trial platform called the Stroke Preclinical Assessment Network (SPAN) to ensure candidate new treatments for acute ischemic stroke are tested systematically and efficiently in rodents. The NIH is calling on researchers to make...

    https://mschristian.org/index.php/blog/nih-trial-aims-to-improve-drug-discovery-for-ischemic-stroke
  • What to know about optic neuritis and MS

    neuritis. Although the symptoms of optic neuritis tend to subside over time, some people may also benefit from various treatments. Visual disturbances are among the most common symptom that people with MS have. One study found that optic neuritis is the...

    https://mschristian.org/index.php/blog/what-to-know-about-optic-neuritis-and-ms
  • What to know about MS in children

    difficulties in performing daily tasks and can greatly affect a person's quality of life. There is no cure, and treatments focus on preventing and reducing MS symptoms. MS is not as common in children as it is in adults. When it does develop in...

    https://mschristian.org/index.php/blog/what-to-know-about-ms-in-children-1
  • Rejuvenating brain stem cells may hold key to future MS treatments

    Scientists have found a way to make older brain stem cells in rats more youthful. The discovery could lead to improved treatments for aging-related diseases that degrade the brain and nervous system. Researchers managed to rejuvenate stem cells,...

    https://mschristian.org/index.php/blog/rejuvenating-brain-stem-cells-may-hold-key-to-future-ms-treatments
  • A Cheap Biotech Stock Tests a Novel Treatment for Multiple Sclerosis - Barron's

    showed hints of actually improving the condition of MS patients, instead of just slowing the disease like most available treatments. If subsequent trials over the next few years confirm the treatment’s effectiveness, Atara could enter the market for MS...

    https://mschristian.org/index.php/blog/a-cheap-biotech-stock-tests-a-novel-treatment-for-multiple-sclerosis-barron-s
  • Society-Funded Investigators Discover New Avenues for Developing Treatments for Progressive MS

    August 13, 2019 These results may help direct the development of new treatments aimed at these brain lesions to stop MS progression. The team is led by Daniel Reich, MD, PhD, and includes Martina Absinta, MD, PhD, who is funded by a postdoctoral...

    https://mschristian.org/index.php/blog/society-funded-investigators-discover-new-avenues-for-developing-treatments-for-progressive-ms
  • Study sheds light on brain cell changes in people with MS

    the study found. The findings could shed new light on how the disease progresses and could also help scientists develop treatments. Experts from the University of Edinburgh and the Karolinska Institute in Sweden analysed post-mortem brain samples from...

    https://mschristian.org/index.php/blog/study-sheds-light-on-brain-cell-changes-in-people-with-ms
  • How does MS affect the eyes?

    in people with multiple sclerosis and can include blurred sight, double vision, and vision loss. Multiple sclerosis treatments can help. As with the other symptoms of multiple sclerosis (MS), eye symptoms can appear during a flare and then fade away...

    https://mschristian.org/index.php/blog/how-does-ms-affect-the-eyes-1
  • Multiple sclerosis treatments delay progression of the disease

    An international study finds multiple sclerosis treatments have long-term benefits, and that early treatment is important. The Royal Melbourne Hospital and University of Melbourne-led study is the first to provide evidence that the currently available...

    https://mschristian.org/index.php/blog/multiple-sclerosis-treatments-delay-progression-of-the-disease
  • Management of Relapses in MS

    loss. Sensation abnormalities which are very painful or involve difficulty using a limb may also benefit. The usual treatments for relapses, often called exacerbations, of these illness requires very high doses of corticosteroids for a few days. These...

    https://mschristian.org/index.php/articles/ms-and-demyelinating-diseases/9-management-of-relapses-in-ms
  • Dr Daniel Kantor Highlights MS Treatments and What Is in the Pipeline

    Sept 2019 The field of treatments for multiple sclerosis (MS) has grown quickly in the last 30 years, but the next new class of therapies probably won’t come to market for at least another year and a half, said Daniel Kantor, MD, president of Kantor...

    https://mschristian.org/index.php/blog/dr-daniel-kantor-highlights-ms-treatments-and-what-is-in-the-pipeline
  • Novel PET imaging agent could help guide therapy for brain diseases

    Medicine and Molecular ImagingSummary:Researchers have developed a new PET imaging agent that could help guide and assess treatments for people with various neurological diseases, including Alzheimer's, Parkinson's, and multiple sclerosis. The agent...

    https://mschristian.org/index.php/blog/novel-pet-imaging-agent-could-help-guide-therapy-for-brain-diseases
  • Humira, Rituxan top list of U.S. drugs with biggest price increases: report - Physician's Weekly

    NEW YORK (Reuters) – AbbVie Inc’s arthritis drug Humira and Roche Holding AG’s cancer drug Rituxan topped a list of seven treatments whose combined 2017 and 2018 price hikes accounted for a $5.1 billion increase in U.S. spending, a report released on...

    https://mschristian.org/index.php/blog/humira-rituxan-top-list-of-u-s-drugs-with-biggest-price-increases-report-physician-s-weekly
  • Biogen Strengthens MS & SMA Portfolio as Competition Lurks - Yahoo Finance

    including Avonex, Tysabri, Tecfidera and Plegridy. It is working on strengthening its position further by bringing new treatments. In November 2017, Biogen in-licensed worldwide commercialization rights to Alkermes’ ALKS Vumerity (BIIB098), which the...

    https://mschristian.org/index.php/blog/biogen-strengthens-ms-sma-portfolio-as-competition-lurks-yahoo-finance
  • #ECTRIMS2019 – Tysabri During Pregnancy and After Delivery Seems Safe, Reduces Relapse Risk, Study Finds

    have been emerging issues for women with MS who are pregnant or planning to become pregnant. “We all know that not all treatments are compatible with pregnancy planning, especially second-line treatments which are usually used for highly active MS...

    https://mschristian.org/index.php/blog/ectrims2019-tysabri-during-pregnancy-and-after-delivery-seems-safe-reduces-relapse-risk-study-finds
  • ‘It’s Not A Death Sentence’: Growing Number Of Young Women Being Diagnosed With Multiple Sclerosis - CBS Philly

    — especially women in their 20s and 30s — are being diagnosed with multiple sclerosis. Fortunately, there are several new treatments that allow many patients to live healthy lives. MS can be debilitating, but it doesn’t have to be. A Philadelphia dancer...

    https://mschristian.org/index.php/blog/it-s-not-a-death-sentence-growing-number-of-young-women-being-diagnosed-with-multiple-sclerosis-cbs-philly
  • New compound offers superior therapeutic approach to treat MS

    body, resulting in symptoms that range from numbness and tingling in the arms and legs to blindness and paralysis. While treatments are available to alleviate inflammation, no therapies exist to protect neurons or repair the degraded myelin sheath that...

    https://mschristian.org/index.php/blog/new-compound-offers-superior-therapeutic-approach-to-treat-ms
  • What to know about secondary progressive multiple sclerosis (SPMS)

    to transition to SPMS. In this article, we provide an overview of SPMS, including its classifications, symptoms, causes, treatments, and ways to manage symptoms. What is SPMS? Most people with RRMS will develop SPMS. Multiple sclerosis (MS) is a...

    https://mschristian.org/index.php/blog/what-to-know-about-secondary-progressive-multiple-sclerosis-spms-1

Results 1 - 20 of 64
 
 

Follow Us on Twitter

Follow Us On Twitter - Image